Research graph
References from Assessing the sustainability of fed-batch and continuous process formats for monoclonal antibody manufacturing via bioprocess modeling. Local targets link to admitted publications; unresolved targets remain external evidence.
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Advancing biopharmaceutical manufacturing: economic and sustainability assessment of end-to-end continuous production of monoclonal antibodies
10.1016/j.tibtech.2024.10.007 · 2025 · External reference
Integrated continuous bioprocessing: economic, operational, and environmental feasibility for clinical and commercial antibody manufacture
10.1002/btpr.2492 · 2017 · External reference
A common framework for integrated and continuous biomanufacturing
2021 · External reference
Process design of a fully integrated continuous biopharmaceutical process using economic and ecological impact assessment
10.1002/bit.28234 · 2022 · External reference
End-to-end collaboration to transform biopharmaceutical development and manufacturing
2021 · External reference
Unresolved reference
2006 · External reference
An environmental life cycle assessment of single-use and conventional process technology: comprehensive environmental impacts
2014 · External reference
An environmental life cycle assessment comparison of single-use and conventional process technology for the production of monoclonal antibodies
10.1016/j.jclepro.2012.09.048 · 2013 · External reference
Life-cycle and cost of goods assessment of fed-batch and perfusion-based manufacturing processes for mAbs
2016 · External reference
10.1016/j.nbt.2018.07.005
10.1016/j.nbt.2018.07.005 · External reference
10.1016/j.cogsc.2022.100614
10.1016/j.cogsc.2022.100614 · External reference
Comparison of process mass intensity (PMI) of continuous and batch manufacturing processes for biologics
10.1016/j.nbt.2022.11.002 · 2022 · External reference
Unresolved reference
2009 · External reference
Energy efficiency improvement and cost saving opportunities for the pharmaceutical industry
2008 · External reference
Energy benchmarking in the pharmaceutical industry
2013 · External reference
Unresolved reference
External reference
Energy demand reduction in pharmaceutical cleanrooms through optimization of ventilation
10.1016/j.enbuild.2019.109346 · 2019 · External reference
Risk-based selection of environmental classifications for biopharmaceutical operations
10.5731/pdajpst.2019.010660 · 2021 · External reference
10.1039/d4re00266k
10.1039/d4re00266k · External reference
Chapter 2 - circular economy and life cycle management
2025 · External reference
Unresolved reference
External reference
